Beam Therapeutics, Inc. (BEAM)
24.50
+0.11
(+0.45%)
USD |
NASDAQ |
Oct 02, 16:00
24.50
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Price : 24.50 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 25.00 | 25.48 | 24.21 | 24.50 | 1.499M |
| Oct 01, 2026 | 24.24 | 24.98 | 23.96 | 24.39 | 1.695M |
| Sep 30, 2026 | 24.79 | 25.20 | 24.41 | 24.45 | 1.559M |
| Sep 29, 2026 | 23.88 | 24.76 | 23.88 | 24.52 | 1.638M |
| Sep 28, 2026 | 24.02 | 24.66 | 23.44 | 24.23 | 1.274M |
| Sep 25, 2026 | 24.97 | 24.97 | 23.75 | 24.27 | 1.221M |
| Sep 24, 2026 | 23.88 | 24.81 | 23.16 | 24.66 | 2.284M |
| Sep 23, 2026 | 25.75 | 26.24 | 24.22 | 24.37 | 1.900M |
| Sep 22, 2026 | 25.62 | 26.50 | 25.07 | 25.93 | 1.989M |
| Sep 21, 2026 | 25.45 | 25.66 | 24.83 | 25.26 | 1.704M |
| Sep 18, 2026 | 24.92 | 25.18 | 24.26 | 24.95 | 2.288M |
| Sep 17, 2026 | 24.28 | 25.50 | 24.05 | 24.67 | 2.429M |
| Sep 16, 2026 | 23.41 | 23.65 | 22.67 | 23.10 | 1.821M |
| Sep 15, 2026 | 23.82 | 23.84 | 22.86 | 23.22 | 2.584M |
| Sep 14, 2026 | 24.02 | 24.93 | 23.99 | 24.12 | 1.459M |
| Sep 11, 2026 | 24.64 | 24.76 | 23.95 | 23.99 | 1.194M |
| Sep 10, 2026 | 24.76 | 24.89 | 23.98 | 24.37 | 1.980M |
| Sep 09, 2026 | 26.70 | 26.70 | 25.11 | 25.18 | 2.847M |
| Sep 08, 2026 | 26.76 | 27.30 | 25.04 | 26.83 | 6.179M |
| Sep 04, 2026 | 28.91 | 29.97 | 28.91 | 29.66 | 1.183M |
| Sep 03, 2026 | 29.49 | 29.65 | 28.02 | 29.46 | 1.271M |
| Sep 02, 2026 | 29.27 | 30.18 | 28.23 | 29.29 | 1.293M |
| Sep 01, 2026 | 28.82 | 29.56 | 28.70 | 29.02 | 889435.0 |
| Aug 31, 2026 | 28.82 | 29.82 | 28.33 | 29.43 | 1.309M |
| Aug 28, 2026 | 29.53 | 30.50 | 29.01 | 29.32 | 1.331M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 12.26 |
| Twist Bioscience Corp. | 188.67 |
| Prime Medicine, Inc. | 2.98 |
| Q32 Bio, Inc. | 8.23 |
| Sarepta Therapeutics, Inc. | 17.50 |
Price Related Metrics
| PS Ratio | 16.29 |
| Price to Book Value | 2.370 |
| Earnings Yield | -3.51% |
| Market Cap | 2.530B |